Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Strongbridge Biopharma plc (NASDAQ: SBBP).

Full DD Report for SBBP

You must become a subscriber to view this report.


Recent News from (NASDAQ: SBBP)

Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV(TM), and Ketoconazole on Human Cortisol Production
In Vitro Data Show Preliminary Evidence That Levoketoconazole Inhibits ACTH Secretion and May Have Anti-Tumor Effect on Pituitary Adenoma Cells First Study in Primary Human Adrenal Cells Suggests Levoketoconazole, the Pure 2S,4R Enantiomer of Ketoconazole, May Be a More Potent Inhibit...
Source: GlobeNewswire
Date: November, 20 2018 07:30
Strongbridge Biopharma plc to Present at the Stifel 2018 Healthcare Conference
DUBLIN, Ireland and TREVOSE, Pa., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced t...
Source: GlobeNewswire
Date: November, 05 2018 16:15
Strongbridge Biopharma, Inc (SBBP) CEO Matthew Pauls on Q3 2018 Results - Earnings Call Transcript
Strongbridge Biopharma, Inc (SBBP) Q3 2018 Earnings Conference Call October 31, 2018 09:15 AM ET Executives Lindsay Rocco - Elixir Health Public Relations Matthew Pauls - President and CEO Dr. Fred Cohen - Chief Medical Officer Brian Davis - Chief Financial Officer Analysts ...
Source: SeekingAlpha
Date: November, 02 2018 21:09
ECA, SPOT and VECO among premarket losers on Q3 earnings
Veeco Instruments (NASDAQ: VECO )  -32%  on Q3 earnings . More news on: Veeco Instruments Inc., Ballard Power Systems, Inc., Encana Corporation, Stocks on the move, , Top stock market news, Read more ...
Source: SeekingAlpha
Date: November, 01 2018 09:18
Positive Developments for Treating Patients With Recurrent Malignant Tumors Significant for Novel Therapeutic Strategies
November 1, 2018 Palm Beach, FL – (November 1, 2018) – Multiple myeloma (MM) known as a plasma cell malignancy that affects 14,000 patients per year are fueling the development and clinical activities for new therapies to treat these malignancies. Recent clinical trial resu...
Source: Financial News Media
Date: November, 01 2018 08:00
Today's Research Reports on Stocks to Watch: Strongbridge Biopharma and Clovis Oncology
NEW YORK, NY / ACCESSWIRE / November 1, 2018 / Strongbridge Biopharma was one of the biggest winners in the biotech arena yesterday after announcing a deal with Denmark’s Novo Nordisk. Shares of Clovis Oncology were in the red after reporting third quarter results. RDI Initiates Cov...
Source: ACCESSWIRE IA
Date: November, 01 2018 07:50
Healthcare & Tech leads midday movers (10/31/2018)
More news on: Strongbridge Biopharma, AEterna Zentaris, Inc., Accuray Incorporated, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: October, 31 2018 12:39
Aeterna Zentaris up 59% on Strongbridge/Novo Macrilen deal
Thinly traded nano cap Aeterna Zentaris ( AEZS +58.5% ) is up on a whopping 159x surge in volume in reaction to Strongbridge Biopharma's ( SBBP +39.5% ) out-licensing deal with Novo Nordisk for U.S. and Canadian rights to MACRILEN (macimorelin). More news on: AEterna Zentaris, Inc., St...
Source: SeekingAlpha
Date: October, 31 2018 11:31
Strongbridge Bio up 33% on Macrilen deal with Novo Nordisk
Strongbridge Biopharma ( SBBP +33.1% ) is up on more than triple normal volume in early trade in response to its out-licensing  deal with Novo Nordisk ( NVO +1.8% ) for U.S. and Canadian rights to MACRILEN (macimorelin), used in the diagnosis of adult growth hormone deficiency. ...
Source: SeekingAlpha
Date: October, 31 2018 09:51
Strongbridge Biopharma misses by $0.16, misses on revenue
Strongbridge Biopharma (NASDAQ: SBBP ): Q3 GAAP EPS of -$0.55 misses by $0.16 . More news on: Strongbridge Biopharma, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: October, 31 2018 08:51

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-144.464.364.504.34104,011
2018-12-134.594.484.664.399165,773
2018-12-124.574.6054.714.5651,233
2018-12-114.764.504.804.45414,677
2018-12-104.864.664.9054.58193,127

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-147,04818,90437.2831Short
2018-12-136,23539,37815.8337Cover
2018-12-122,56111,35022.5639Cover
2018-12-1136,393165,29122.0175Cover
2018-12-1023,90550,39247.4381Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on SBBP.


About Strongbridge Biopharma plc (NASDAQ: SBBP)

Logo for Strongbridge Biopharma plc (NASDAQ: SBBP)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $350,387,330 - 05/18/2018
  • Issue and Outstanding: 45,504,848 - 03/01/2018

 


Recent Filings from (NASDAQ: SBBP)

Filing Type: CT ORDERFiling Source: edgar
Filing Date: August, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 28 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: August, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 16 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 08 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: June, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 11 2018
Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 31 2018

 

 


Daily Technical Chart for (NASDAQ: SBBP)

Daily Technical Chart for (NASDAQ: SBBP)


Stay tuned for daily updates and more on (NASDAQ: SBBP)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: SBBP)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in SBBP is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of SBBP and does not buy, sell, or trade any shares of SBBP. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/